Avalon GloboCare
2014
FOUNDED
PUBLIC
STATUS
1-10
EMPLOYEES
AVCO
STOCK SYMBOL
4
INVESTMENTS
$1.53
SHARE PRICE
(As of Monday Closing)
Description
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promote and empower high impact, transformative biotechnology, and their clinical applications, and healthcare facility management. It has three reportable segments: real property operating segment which is the key revenue driver; medical-related consulting services segment; and development services and sales of developed products segment. The company focuses on the diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
NAS
Primary Office
- 4400 Route 9 South
- Suite 3100
- Freehold, NJ 07728
- United States
+1 (732) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Avalon GloboCare’s full profile, request a free trial.
Avalon GloboCare Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $1.40 - $5.63 | $116M | $1.62 | -$0.21 | 176K | 75.8M |
Avalon GloboCare Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 138,033 | 197,289 | 169,790 | 147,329 |
| Revenue | 1,412 | 1,562 | 1,078 | 616 |
| EBITDA | (15,379) | (7,219) | (3,731) | 77 |
| Net Income | (15,275) | (7,774) | (3,464) | 56 |
| Total Assets | 10,669 | 13,396 | 12,669 | 3,707 |
| Total Debt | 590 | 1,000 | 1,500 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Avalon GloboCare Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Avalon GloboCare‘s full profile, request access.
Request full access to PitchBookAvalon GloboCare Investments & Acquisitions (4)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 000000000 | 23-Oct-2018 | 00000 0000000 | Drug Discovery | 00000 000 00.0 | |
| 000000 0000000 | 01-Sep-2018 | 00000 0000000 | Biotechnology | 00000 000 00.0 | |
| 0000000 0000000 (0 | 25-Oct-2017 | 000000000000000000 | 00000 | Drug Discovery | 00000 000 00.0 |
| Freehold Executive Center | 05-May-2017 | Corporate Asset Purchase | 00.000 | Buildings and Property | 00000 000 00.0 |
Avalon GloboCare Executive Team (5)
1 Former Executive
You’re viewing 4 of 5 executives. Get the full list »Avalon GloboCare Board Members (4)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 00000 000 00.0 | Avalon GloboCare | Chief Executive Officer & Board Member | 000 0000 | |
| 0000 00 | Avalon GloboCare | Chief Operating Officer & Board Member | 000 0000 | |
| 0000000 000000 | Avalon GloboCare | Board Member | 000 0000 | |
| 0000000 0000000 000 | Self | Board Member | 000 0000 |